A detailed history of Rappaport Reiches Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rappaport Reiches Capital Management, LLC holds 9,050 shares of ABBV stock, worth $1.81 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
9,050
Previous 9,225 1.9%
Holding current value
$1.81 Million
Previous $1.58 Billion 12.95%
% of portfolio
0.48%
Previous 0.47%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$163.84 - $199.33 $28,672 - $34,882
-175 Reduced 1.9%
9,050 $1.79 Billion
Q2 2024

Jul 18, 2024

SELL
$154.79 - $180.76 $1.1 Million - $1.28 Million
-7,090 Reduced 43.46%
9,225 $1.58 Billion
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $1.19 Million - $1.36 Million
7,447 Added 83.98%
16,315 $2.97 Billion
Q4 2023

Jan 24, 2024

BUY
$137.6 - $154.97 $23,392 - $26,344
170 Added 1.95%
8,868 $1.37 Billion
Q3 2023

Oct 10, 2023

SELL
$133.59 - $154.65 $37,672 - $43,611
-282 Reduced 3.14%
8,698 $1.3 Billion
Q2 2023

Aug 23, 2023

SELL
$132.51 - $164.9 $23,189 - $28,857
-175 Reduced 1.91%
8,980 $1.21 Billion
Q1 2023

Aug 23, 2023

SELL
$144.61 - $166.54 $34,851 - $40,136
-241 Reduced 2.56%
9,155 $1.46 Billion
Q4 2022

Aug 23, 2023

SELL
$138.31 - $165.87 $32,226 - $38,647
-233 Reduced 2.42%
9,396 $1.52 Billion
Q3 2022

Aug 23, 2023

SELL
$134.21 - $153.93 $35,028 - $40,175
-261 Reduced 2.64%
9,629 $1.29 Billion
Q2 2022

Aug 23, 2023

SELL
$137.62 - $174.96 $1,789 - $2,274
-13 Reduced 0.13%
9,890 $1.51 Billion
Q1 2022

Aug 23, 2023

BUY
$131.98 - $163.75 $252,345 - $313,090
1,912 Added 23.93%
9,903 $1.61 Billion
Q4 2021

Aug 23, 2023

BUY
$107.43 - $135.93 $97,761 - $123,696
910 Added 12.85%
7,991 $1.08 Billion
Q3 2021

Aug 23, 2023

SELL
$106.4 - $120.78 $7,448 - $8,454
-70 Reduced 0.98%
7,081 $764 Million
Q2 2021

Aug 22, 2023

BUY
$105.21 - $117.21 $752,356 - $838,168
7,151 New
7,151 $805 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rappaport Reiches Capital Management, LLC Portfolio

Follow Rappaport Reiches Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rappaport Reiches Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rappaport Reiches Capital Management, LLC with notifications on news.